AbstractObjectivesTo analyze the immunogenicity of virus-like particles (VLP) of human papillomavirus type 16 (HPV16) isolated in East China and the adjuvant potential of interleukin-12 (IL-12).MethodsThe variant HPV16 L1VLP expressed in sf9 insect cells were purified with cesium chloride gradient centrifugation. BALB/c mice were vaccinated with VLP (L1N), VLP with Freund's adjuvant (L1A) or VLP with IL-12 recombinant plasmid (L1P). HPV16 VLP specific IgG and IFN-γ level in the serum were detected by ELISA, and the percentage of CD4+ and CD8+ in spleen cells was detected with flow cytometry.ResultsThe titers of serum IgG antibodies in vaccinated groups were higher than in negative control and the serum antibodies mainly recognized conformat...
Human papillomaviruses (HPVs) cause warts and have also been associated closely with human malignan...
Background and Objectives: Human papilloma virus (HPV) is known as the etiologic agent of cervical c...
To specifically induce a mucosal antibody response to purified human papillomavirus type 16 (HPV16) ...
AbstractHere, we report the enhanced mucosal and systemic immunogenicity of human papillomavirus typ...
AbstractHuman papillomavirus-like particles (HPV VLP) are candidate vaccines that have shown to be e...
Background: Various promising procedures have been used to improve the potency of DNA vaccines for t...
Viruslike particles (VLPs) produced from the L1 protein of several papillomaviruses have induced pro...
To enhance the efficacy of a therapeutic immunisition strategy against human papillomavirus-induced ...
OBJECTIVE: To confirm human papillomavirus (HPV) 6b virus-like particles (VLP) have strong immunogen...
Human papillomavirus type 16 (HPV-16) infects the genital tract and is closely associated with the d...
AbstractGenital HPV genotypes are generally distinct serotypes, but whether variants within a genoty...
Human papillomavirus (HPV) vaccines confer protection against the oncogenic genotypes HPV16 and HPV1...
Cervical cancer results from cervical infection by human papillomaviruses (HPV), especially HPV16. I...
Abstract Background Persistent infection of human papillomavirus (HPV) types 16 and 18 causes cervic...
Attenuated strains of Salmonella are attractive live vaccine candidates for eliciting mucosal as wel...
Human papillomaviruses (HPVs) cause warts and have also been associated closely with human malignan...
Background and Objectives: Human papilloma virus (HPV) is known as the etiologic agent of cervical c...
To specifically induce a mucosal antibody response to purified human papillomavirus type 16 (HPV16) ...
AbstractHere, we report the enhanced mucosal and systemic immunogenicity of human papillomavirus typ...
AbstractHuman papillomavirus-like particles (HPV VLP) are candidate vaccines that have shown to be e...
Background: Various promising procedures have been used to improve the potency of DNA vaccines for t...
Viruslike particles (VLPs) produced from the L1 protein of several papillomaviruses have induced pro...
To enhance the efficacy of a therapeutic immunisition strategy against human papillomavirus-induced ...
OBJECTIVE: To confirm human papillomavirus (HPV) 6b virus-like particles (VLP) have strong immunogen...
Human papillomavirus type 16 (HPV-16) infects the genital tract and is closely associated with the d...
AbstractGenital HPV genotypes are generally distinct serotypes, but whether variants within a genoty...
Human papillomavirus (HPV) vaccines confer protection against the oncogenic genotypes HPV16 and HPV1...
Cervical cancer results from cervical infection by human papillomaviruses (HPV), especially HPV16. I...
Abstract Background Persistent infection of human papillomavirus (HPV) types 16 and 18 causes cervic...
Attenuated strains of Salmonella are attractive live vaccine candidates for eliciting mucosal as wel...
Human papillomaviruses (HPVs) cause warts and have also been associated closely with human malignan...
Background and Objectives: Human papilloma virus (HPV) is known as the etiologic agent of cervical c...
To specifically induce a mucosal antibody response to purified human papillomavirus type 16 (HPV16) ...